C

Cibus Inc
NASDAQ:CBUS

Watchlist Manager
Cibus Inc
NASDAQ:CBUS
Watchlist
Price: 2.31 USD -4.94% Market Closed
Market Cap: 79.3m USD

Cibus Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cibus Inc
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Cibus Inc
NASDAQ:CBUS
Net Income
-$282.7m
CAGR 3-Years
-113%
CAGR 5-Years
-48%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income
$4.3B
CAGR 3-Years
-28%
CAGR 5-Years
-11%
CAGR 10-Years
9%
Gilead Sciences Inc
NASDAQ:GILD
Net Income
$3.4B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Net Income
$5.9B
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
0%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income
-$988.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-3%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income
$4.5B
CAGR 3-Years
-17%
CAGR 5-Years
15%
CAGR 10-Years
29%

Cibus Inc
Glance View

Market Cap
79.3m USD
Industry
Biotechnology

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California and currently employs 228 full-time employees. The company went IPO on 2017-07-20. The firm is engaged in developing and licensing plant traits to seed companies for royalties on seed sales. The firm is involved in gene-edited trait development, where plant traits (or specific genetic characteristics) that are indistinguishable from traits developed using traditional breeding are created using gene editing. Its patented RTDS technology platform includes the Trait Machine, which is a semi-automated stand-alone trait production facility. The Company’s Trait Machine materially changes the speed, breadth, and scale of trait development. The company is focused on the development of productivity traits and sustainable ingredients. The firm focuses on developing traits for addressing the sustainability challenges presented by climate change, disease, and pests.

CBUS Intrinsic Value
20.21 USD
Undervaluation 89%
Intrinsic Value
Price
C

See Also

What is Cibus Inc's Net Income?
Net Income
-282.7m USD

Based on the financial report for Dec 31, 2024, Cibus Inc's Net Income amounts to -282.7m USD.

What is Cibus Inc's Net Income growth rate?
Net Income CAGR 5Y
-48%

Over the last year, the Net Income growth was 16%. The average annual Net Income growth rates for Cibus Inc have been -113% over the past three years , -48% over the past five years .

Back to Top